CEO: Merck on pace to distribute tens of millions of doses of COVID-19 antiviral pills if approved | The Hill: Healthcare Policy

admin October 28, 2021

The CEO of Merck said during an interview on CNBC that the biopharmaceutical company was on pace to distribute tens of millions of the COVID-19 antiviral pill it developed with Ridgeback Biotherapeutics once it receives federal approval.“Right now...